Legal & General Group Plc purchased a new position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the second quarter, according to its most recent filing with the SEC. The firm purchased 1,102,793 shares of the semiconductor company’s stock, valued at approximately $491,923,000.
Several other hedge funds have also recently made changes to their positions in the business. Sankala Group LLC bought a new stake in shares of Synopsys during the 4th quarter valued at about $25,000. Elevation Wealth Partners LLC increased its holdings in Synopsys by 96.4% in the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after purchasing an additional 27 shares in the last quarter. Osbon Capital Management LLC bought a new stake in Synopsys in the second quarter worth approximately $25,000. IMG Wealth Management Inc. acquired a new position in Synopsys in the second quarter valued at approximately $28,000. Finally, Caitong International Asset Management Co. Ltd acquired a new position in Synopsys in the fourth quarter valued at approximately $28,000. 85.47% of the stock is owned by institutional investors.
Synopsys Price Performance
Shares of NASDAQ SNPS opened at $408.79 on Wednesday. The stock has a market cap of $78.28 billion, a price-to-earnings ratio of 94.63, a PEG ratio of 2.32 and a beta of 1.23. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43. Synopsys, Inc. has a fifty-two week low of $366.00 and a fifty-two week high of $615.79. The firm’s 50-day simple moving average is $417.74 and its 200 day simple moving average is $439.85.
Insider Activity at Synopsys
In related news, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the transaction, the chief financial officer owned 14,358 shares of the company’s stock, valued at $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the company’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the sale, the chief executive officer owned 75,020 shares of the company’s stock, valued at $34,431,179.20. This trade represents a 16.29% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is owned by insiders.
Analyst Upgrades and Downgrades
A number of research firms have issued reports on SNPS. Morgan Stanley cut their price target on Synopsys from $525.00 to $500.00 and set an “equal weight” rating on the stock in a report on Wednesday, August 19th. Needham & Company LLC reiterated a “buy” rating and set a $580.00 target price on shares of Synopsys in a research report on Thursday, May 28th. Stifel Nicolaus increased their target price on shares of Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Berenberg Bank set a $633.00 price target on shares of Synopsys in a research note on Wednesday, May 27th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Synopsys in a report on Monday, June 8th. Eleven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $563.59.
Check Out Our Latest Analysis on Synopsys
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
